AbbVie ABBV reported its Q2 earnings results on Friday, July 29, 2022 at 07:44 AM.
Here's what investors need to know about the announcement.
AbbVie beat estimated earnings by 1.2%, reporting an EPS of $3.37 versus an estimate of $3.33.
Revenue was up $624.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 6.03% drop in the share price the next day.
Here's a look at AbbVie's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
AbbVie management provided guidance for Q2 2022, expecting earnings between $3.24 and $3.28 per share.
To track all earnings releases for AbbVie visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.